Related Experiment Video
Updated: Jul 18, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Adrenal tumors with late enhancement on CT and MRI
Byung Kwan Park1, Chan Kyo Kim, Bohyun Kim
1The Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul, 135-710, South Korea. rapark@skku.edu
Objectives:
To identify adrenal masses showing gradual persistent enhancement on delayed contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI).
Materials And Methods:
Computed tomography or magnetic resonance images of pathologically proven 400 adrenal tumors were retrospectively reviewed over a 10-year period. We included only adrenal tumors showing gradual persistent enhancement on CT and MRI performed at 15 and 5 min, respectively, after contrast material injection.
Results:
Four tumors in four patients (three men and one woman; mean age, 51 years) met the inclusion criteria. These lesions were as follows: two ganglioneuromas, one myelolipoma with infarction, and one angiomyolipoma with minimal fat. All of these tumors showed gradual persistent enhancement, and highest attenuation during delayed contrast-enhanced CT or strongest enhancement during delayed contrast-enhanced MRI.
Conclusion:
The differential diagnosis of adrenal tumors showing gradual persistent enhancement on delayed contrast-enhanced CT and MRI should include ganglioneuroma, myelolipoma with infarction, and angiomyolipoma with minimal fat.
